These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 218151)

  • 1. Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
    Nachtigall LE; Nachtigall RH; Nachtigall RD; Beckman EM
    Obstet Gynecol; 1979 Mar; 53(3):277-81. PubMed ID: 218151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
    Gelfand MM; Ferenczy A
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
    Bewtra C; Kable WT; Gallagher JC
    J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estrogen (HOPE) trial.
    Thorneycroft IH; Lindsay R; Pickar JH
    Am J Obstet Gynecol; 2007 Aug; 197(2):137.e1-7. PubMed ID: 17689624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy.
    Luciano AA; De Souza MJ; Roy MP; Schoenfeld MJ; Nulsen JC; Halvorson CV
    J Reprod Med; 1993 Mar; 38(3):207-14. PubMed ID: 8487239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
    Ramsey-Goldman R
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):72-3. PubMed ID: 16932632
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.
    Soma MR; Osnago-Gadda I; Paoletti R; Fumagalli R; Morrisett JD; Meschia M; Crosignani P
    Arch Intern Med; 1993 Jun; 153(12):1462-8. PubMed ID: 8390232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hormone replacement therapy in endometrial polyp formation.
    Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
    Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inconveniences and risks of untreated menopause. Benefits brought by the replacement hormonal treatment].
    Drapier-Faure E
    Rev Fr Gynecol Obstet; 1992; 87(7-9):393-6. PubMed ID: 1332177
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic hormonetherapy. A report on 305 cases.
    Ramont CB
    Geriatrics; 1966 Nov; 21(11):212-5. PubMed ID: 4288699
    [No Abstract]   [Full Text] [Related]  

  • 19. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.